Banzai International (Nasdaq: BNZI) just made a move that could fundamentally reshape what the microcap marketing technology company looks like by summer — and the numbers tell a striking story.
The Austin-based AI marketing platform announced late last week that it has reached terms to acquire the assets of ConnectAndSell, an AI-powered sales acceleration platform serving B2B organizations across healthcare, financial services, and technology. The deal, structured around a non-binding letter of intent, is expected to close in early Q2 2026, pending a definitive agreement and customary closing conditions.
The strategic rationale is straightforward on paper: Banzai recorded approximately $10.65 million in revenue over the trailing twelve months ending Q3 2025. The ConnectAndSell acquisition is projected to add roughly $15 million in annual revenue — meaning the deal alone would more than double the company’s current revenue run rate if integration goes according to plan. For a company with a market cap hovering around $14 million, that kind of top-line expansion isn’t incremental — it’s transformational.
ConnectAndSell is not a startup. It is an established, profitable business with a track record of generating real revenue across enterprise and mid-market accounts. Its platform is designed to dramatically increase sales team productivity by maximizing time spent in live conversations with qualified decision-makers — a capability that sits at the highest-value stage of the go-to-market funnel. For Banzai, which already helps companies target, engage, and measure marketing outcomes, layering in sales execution capabilities creates an end-to-end revenue platform that few companies at this market cap can claim.
The deal follows Banzai’s acquisition of Superblocks in November 2025, an agentic AI platform for SEO-optimized website development. The pattern is becoming clear: Banzai is pursuing a deliberate build-out strategy, acquiring profitable, AI-native tools that are immediately accretive and strategically complementary rather than chasing speculative moonshots.
Cross-sell opportunity is a core part of the investment thesis here. Banzai’s existing customer base includes more than 140,000 organizations — among them RBC, Dell Technologies, New York Life, and Thermo Fisher Scientific. Introducing ConnectAndSell’s sales acceleration capability to even a fraction of that base could generate meaningful incremental revenue beyond the $15 million headline figure.
Still, investors should keep a few realities in check. The transaction remains at the letter of intent stage — no definitive agreement has been signed, and no purchase price has been disclosed, creating near-term financial transparency uncertainty. Banzai’s stock has also declined roughly 89% over the past year, sitting just below the $1 mark, which reflects a company that has been fighting uphill on the balance sheet even as it executes strategically. Management is scheduled to discuss the proposed acquisition in detail on a conference call March 31, 2026 at 4:30 p.m. Eastern Time, which will be the next critical data point for investors watching this deal develop.
For small and microcap investors, Banzai’s acquisition playbook is worth watching. In a market where platform consolidation is increasingly the path to survival and scale, companies that can string together profitable, AI-powered assets at reasonable valuations may be positioning themselves for an outsized rerating when the market conditions turn. Whether BNZI can execute on that vision is the question the rest of 2026 will answer.